Literature DB >> 8292555

A murine model of experimental autoimmune lens-induced uveitis using Klebsiella O3 lipopolysaccharide as a potent immunological adjuvant.

T Yokochi1, Y Fujii, I Nakashima, J Asai, M Kiuchi, K Kojima, N Kato.   

Abstract

Experimental autoimmune uveitis and finally panophthalmitis could be produced in mice by repeated immunization of syngeneic eyeball extract mixed with Klebsiella O3 lipopolysaccharide (KO3 LPS) as a powerful immunological adjuvant. No ocular lesions were produced in mice given eyeball extract emulsified in complete Freund's adjuvant (CFA), KO3 LPS alone or eyeball extract alone. Histopathological changes in the ocular lesions at the early stage after the second or tertiary immunization were characterized by infiltration with inflammatory cells in the ciliary body and iris. The iridocyclitis was followed by extensive infiltration of polymorphonuclear leucocytes (PMN) into the cornea, lens and the surrounding tissues after repeated immunization. Finally, these areas were replaced by granulomatous tissues infiltrated with mononuclear cells. On the other hand, the structure of the retina and sclera was partially preserved. Those mice exhibited production of autoantibodies and development of the delayed-type hypersensitivity (DTH) to syngeneic eyeball extract. Moreover, ocular lesions could be produced in normal recipient mice by transfer of sensitized lymphocytes from hyperimmunized mice. Therefore, it was suggested that the ocular lesions produced by repeated immunization with the mixture of eyeball extract and KO3 LPS were due to the autoimmune mechanism. This might be useful to model immunological phenomena in the pathogenesis of human phacoantigenic uveitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292555      PMCID: PMC2002260     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  17 in total

1.  Microbial adjuvant and autoimmunity. II. Production of lesions in mice immunized with syngeneic tissue extracts together with the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  I Nakashima; T Yokochi; N Kato; J Asai
Journal:  Microbiol Immunol       Date:  1977       Impact factor: 1.955

2.  Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae.

Authors:  J Kuriki; H Murakami; S Kakumu; N Sakamoto; T Yokochi; I Nakashima; N Kato
Journal:  Gastroenterology       Date:  1983-03       Impact factor: 22.682

3.  Experimental autoimmune hemolytic anemia in mice induced by repeated immunization with ultrasonicated syngeneic erythrocytes together with Klebsiella O3 lipopolysaccharide.

Authors:  T Kato; H Yamada; T Yokochi; I Nakashima; N Kato
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1984-07

4.  Comparison of the ocular effects of circulating endotoxin and immune complexes: role of vasoactive amines.

Authors:  E L Howes; D G McKay
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

5.  Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action.

Authors:  T Yokochi; Y Inoue; Y Kimura; N Kato
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

6.  Retention of bacterial lipopolysaccharide at the site of subcutaneous injection.

Authors:  T Yokochi; Y Inoue; J Yokoo; Y Kimura; N Kato
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  Microbial adjuvant and autoimmunity. IV. Production of lesions in the exocrine pancreas of mice by repeated injection of syngeneic pancreatic extract together with the capsular polysaccharide of Klebsiella pneumoniae.

Authors:  K Yamaki; M Ohta; I Nakashima; A Noda; J Asai; N Kato
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

8.  Characterization of autoantigens relevant to autoimmune ophthalmitis and thyroiditis in mice immunized with the syngeneic tissue extracts and Klebsiella O3 lipopolysaccharide.

Authors:  T Yokochi; K Oka; H Iwata; T Miyadai; Y Kimura; N Kato
Journal:  Microbiol Immunol       Date:  1987       Impact factor: 1.955

9.  Strong adjuvanticity of bacterial lipopolysaccharides possessing the homopolysaccharides consisting of mannose as the O-specific polysaccharide chains.

Authors:  N Kato; M Ohta; N Kido; S Naito; I Nakashima; F Nagase; T Yokochi
Journal:  Med Microbiol Immunol       Date:  1985       Impact factor: 3.402

10.  Further Studies of the polysaccharide of Klebsiella pneumoniae possessing strong adjuvanticity. I. Production of the adjuvant polysaccharide by noncapsulated mutant.

Authors:  M Ohta; M Mori; T Hasegawa; F Nagase; I Nakashima; S Naito; N Kato
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

View more
  5 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  The role of lipopolysaccharide injected systemically in the reactivation of collagen-induced arthritis in mice.

Authors:  S Yoshino; M Ohsawa
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice.

Authors:  S Yoshino; E Sasatomi; M Ohsawa
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

4.  Binding of mannose-binding protein to Klebsiella O3 lipopolysaccharide possessing the mannose homopolysaccharide as the O-specific polysaccharide and its relation to complement activation.

Authors:  G Z Jiang; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

5.  Augmented immunological activities of recombinant lipopolysaccharide possessing the mannose homopolymer as the O-specific polysaccharide.

Authors:  N Paeng; N Kido; G Schmidt; T Sugiyama; Y Kato; N Koide; T Yokochi
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.